IBRX Financing Cash Flow
Immunitybio Inc · Financing Cash Flow
IBRX Financing Cash Flow
Latest reported$496.78Mperiod ending
IBRX Cash from Financing ($905.00K → $496.78M)
Annual financing cash flow
High-resolution chart · PNG
IBRX financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 400,241,000 | |
| 281,630,000 | |
| 558,341,000 | |
| 233,613,000 | |
| 505,443,000 | |
| 150,675,000 | |
| 114,279,000 | |
| -771,000 | |
| -34,983,000 | |
| -15,560,000 | |
| 317,333,000 | |
| 64,407,000 | |
| 905,000 |